News

Court reviews current status of the Levaquin (Fluoroquinolones) MDL

The United States District Court for the District of Minnesota issued a conference to oversee the current status of the Fluoroquinolones Antibiotics MDL (Levaquin, Avelox and Cipro). Centralized by the U.S. Judicial Panel on Multidistrict Litigation (JMPL) in August...

New study found Abilify’s adverse reactions outweigh its benefits

A new study found that the antidepressant effects of Abilify (aripiprazole) are so minimal that its risks significantly outweigh the alleged benefits. The medication manufactured by Bristol-Myers Squibb is one of the most controversial ones actually sold in the U.S....

Bayer wins Xarelto Bellwether trial for the third time

For the third time in a row, Bayer and Janssen Pharmaceutical won the Xarelto bellwether trial scheduled for August 2017. A federal jury in the U.S. District Court, Southern District of Mississippi, handed a favorable verdict to the manufacturers against a plaintiff...

RA drug Actemra linked to deaths — victims filed a lawsuit

After the Rheumatoid Arthritis (RA) drug Actemra (tocilizumab) has been linked to thousands of death cases, many victims decided to file a lawsuit. According to a study recently published by STAT, this innovative medication's side...

The Big Pharma won the second Xarelto bellwether trial

The second Xarelto bellwether trial ended with a victory for the defendants Johnson & Johnson and Bayer AG. The federal jury's verdict confirmed the decision of the first trial, clearing the manufacturers of any liability for the serious injuries suffered by...

Is there a conspiracy behind the Xarelto lawsuits?

Authoritative and influential individuals recently spoke to the news about a potential Xarelto lawsuit conspiracy. Is there any truth behind their words? The Xarelto MDL is one of the largest litigation in the recent American history, racking up to 18,000 lawsuits...

Judge chose four plaintiff experts in upcoming Xarelto trial

Honorable Judge Eldon E. Fallon recently chose four experts as witnesses during the upcoming Xarelto trial that has been scheduled for April 24, 2017. Defendants Bayer and Janssen tried to exclude them from providing testimony on behalf of the almost 17,000 plaintiffs...

Xarelto first bellwether trial pushed to April 2017

The first Xarelto bellwether trial has been pushed by another month and is now scheduled to begin in April 2017. This is the third time both parties agree to reschedule the four trials which are now set to begin in April, May, June and July. Last time the trial was...